Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Variable region of light chain and heavy chain genes of anti-KDR monoclonal antibody and its use

A variable region and antibody technology, applied in the application field of diagnosis and therapeutic drugs, can solve the problems of limited application and achieve the effect of wide application prospects

Inactive Publication Date: 2008-06-04
INST OF HEMATOLOGY & BLOOD HOSPITAL CHINESE ACAD OF MEDICAL SCI
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] However, the human anti-mouse antibody (HAMA) reaction generated when the mouse monoclonal antibody is used as a heterologous protein is a major defect that limits its application.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Variable region of light chain and heavy chain genes of anti-KDR monoclonal antibody and its use
  • Variable region of light chain and heavy chain genes of anti-KDR monoclonal antibody and its use
  • Variable region of light chain and heavy chain genes of anti-KDR monoclonal antibody and its use

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0020] Example 1, Cloning of Anti-KDR Antibody Light and Heavy Chain Variable Region Genes

[0021] 1. Extraction of total RNA: extract total RNA,

[0022] 2. Reverse transcription: Take 2μg total RNA and place it in a 0.5ml Eppendorf tube, add 5×RTbuffer, 0.1M DTT, 100ng random primers, 10nmol each of 4×dNTP, Rnasin 20U, put in a water bath at 65°C for 5-10min, then add 200U of M-MLV reverse transcriptase, placed in a 37°C water bath for 1 hour, then transferred to a 72°C water bath for 10 minutes.

[0023] 3. PCR amplification of the light and heavy chain variable region genes: Take 8 μl of the reverse transcription product and put it in a PCR tube, add 2 μl of 10mM dNTP, 10 μl of 10×PCR buffer, 2U of Pyrobest DNA polymerase, and use universal degenerate primers P1 and P2 respectively , 30pmol each of P3 and P4 specifically amplified the heavy chain and light chain variable region genes of the antibody, and introduced MuI I and Not I restriction endonuclease sites at the 5...

Embodiment 2

[0030] Example 2, Construction of Single Chain Antibody Gene Expression Vector pAYZKDR ScFv

[0031] According to the enzyme cleavage map of the light and heavy chain variable regions and the enzyme cleavage site of the construction vector pAYZ, designed and synthesized for V H , V L Primers for gene amplification and splicing. First, primers P5, P6, P7, and P8 were used to amplify the heavy chain and light chain variable region genes respectively, and then the antibody light and heavy chain variable region genes were amplified with a DNA fragment encoding (G4S)3 short peptide by the overlap-PCR method. spliced ​​into 5′V H -Linker-V L 3' fragment, and finally use P5 and P8 to amplify the full-length ScFv gene, and introduce Mull I and Not I restriction endonuclease sites at the 5' end and 3' end respectively. The gene was loaded into the pAYZ expression vector, constructed as figure 1 The indicated anti-KDR ScFv expression vector pAYZKDR ScFv.

[0032] The above three P...

Embodiment 3

[0038] Example 3. Expression, purification and renaturation of anti-KDR ScFv antibody fragments

[0039] 1. Expression of anti-KDR ScFv antibody fragments

[0040] Transform E.Coli 16C9 with the constructed pAYZKDR ScFv plasmid, pick a single colony and inoculate it in 5ml of 2×YT medium containing 100mg / L ampicillin (each 1000ml contains 16g of peptone, 10g of yeast extract, 5g of sodium chloride, pH 7.4 ), 37°C, 250rpm, shaking culture for 10h; 4000rpm, 4°C centrifugation for 10min to collect the bacteria, resuspended in 20ml induction medium containing 100mg / L ampicillin (1.5g glucose, 11g tyrosine protein hydrolyzate per 1000ml , yeast extract 0.6g magnesium sulfate 0.19g, ammonium chloride 1.07, potassium chloride 3.73g, sodium chloride 1.2g, 1mol / L triethanolamine 120ml, pH7.4), 30°C, 250rpm, shaking culture for 24h; The cells were collected by centrifugation at 8000 rpm and 4°C for 10 min.

[0041] The cell pellet was resuspended in 1 / 30 culture volume of ice-precoole...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses the variable region of light chain and heavy chain genes of anti-KDR monoclonal antibody and its use, polypeptides encoded by the gene, the carrier containing the gene the use of them in diagnosing and preparing medicament for treating Angiogenesis (in particular tumor Angiogenesis). The prepared anti-KDR ScFv preserves the recognition function of the murine monoclonal antibody to KDR antigens.

Description

technical field [0001] The present invention relates to anti-KDR (kinase insert domain-containing receptor, KDR, VEGFR-2, human vascular endothelial growth factor receptor II) monoclonal antibody Ycom1D3 heavy chain and light chain variable region genes, polypeptides encoded by the genes, The carrier containing the gene and the application of the gene and polypeptide in the preparation of diagnosing and treating drugs for angiogenesis diseases (especially tumor angiogenesis). Specifically, the heavy chain and light chain variable region genes of the present invention are derived from anti-KDR monoclonal antibody Ycom1D3. Background technique [0002] Malignant tumors are one of the most important diseases in my country, and tumor angiogenesis is the basis of tumor growth and metastasis. When a solid tumor grows beyond 1mm-2mm in diameter, the intervention and maintenance of new blood vessels is necessary, otherwise it will cause tumor necrosis and apoptosis. dead or dormant ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N15/13C12N15/11C12N15/63C07K16/28C07K16/30A61K38/16A61P35/00G01N33/68C07H21/04C07K14/435C07K14/47C07K16/18
Inventor 杨纯正李容熊冬生邵晓枫许元富彭晖杨铭王金宏纪庆范冬梅王彩云齐静
Owner INST OF HEMATOLOGY & BLOOD HOSPITAL CHINESE ACAD OF MEDICAL SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com